Please click below to access the 2021 Behavioral Neurology & Neuropsychiatry reading list.
The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content.
To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within ten business days of passing the quiz.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.
The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy.
Robin A. Hurley, MD, FANPA, W.G. Hefner VA Medical Center Disclosures: Employee of the Veterans Administration (VA). VA received research funding from Teva Pharma for posttraumatic migraine study, Aptinyx, Inc for PTSD and sleep study, and Avanir Pharmaceuticals for traumatic brain injury and aggression study. Role: Principal investigator. VA received research funding for the million veteran program, the MIRECC, relating to PTSD and TBI, funding for a genetics study called PRIME, and funding for a study of suvorexant for PTSD-related insomnia. No personal compensation received related to the research funding received. James R. Bateman, III, MD, Wake Forest School of Medicine Disclosures: Nothing to disclose. Donald P. Eknoyan, MD, Kaiser Permanente Disclosures: Nothing to disclose. Kyle J. Steinman, MD, MAS, University of Washington/Seattle Children's Hospital Disclosures: Received research funding from a government organization. Colin J. Harrington, MD, Rhode Island Hospital and Brown University Medical School Disclosures: Nothing to disclose. Claudia R. Padilla, MD, Baylor Scott & White AT&T Memory Center Disclosures: Nothing to disclose. Jonathan H. Woodcock, MD, University of Colorado – Anschutz Medical Campus Disclosures: Nothing to disclose. Michael J. Schrift, DO, MA, FANPA, University of Washington Department of Psychiatry and Behavioral Science Disclosures: Nothing to disclose. Miles G. Cunningham, MD, McLean Hospital Disclosures: Nothing to disclose. Mary E. Quiceno, MD, University of North Texas Health Science Center Disclosures: Serve as Appeals Advisory Panel member for NFL Concussion Injury Litigation/Settlement Program. Employed by Parexel as a Medical Director.
Bryan Hagerla, Continuous Certification Manager [email protected] (612) 928-6326